USPTO trademark

Resilient Pharmaceuticals, Inc design mark 50165260

Under examinationUSPTOFigurative markClass 5

"Design mark 50165260" is a figurative mark owned by Resilient Pharmaceuticals, Inc., filed at the USPTO on October 16, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
Resilient Pharmaceuticals, Inc design mark 50165260 trademark as filed
As filed with the USPTO
Status
Under examination
Since October 16, 2026
Filed
October 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50165260
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Resilient Pharmaceuticals, Inc design mark 50165260

The owner and representative on file with the office.

Owner

Resilient Pharmaceuticals, Inc.

Lake Forest, United States

Representative

Karen K. Won

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Goods and services

What the mark covers

The products and services Resilient Pharmaceuticals, Inc design mark 50165260 is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, prescription psychotropics; Psychotropic preparations for the treatment of psychiatric and psychological diseases and disorders; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About Resilient Pharmaceuticals, Inc design mark 50165260

Who owns the trademark "Design mark 50165260"?

The USPTO trademark "Design mark 50165260" (application 50165260) is owned by Resilient Pharmaceuticals, Inc.

What is the status of "Design mark 50165260"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Resilient Pharmaceuticals, Inc design mark 50165260 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a149f6-8809-745a-8ff5-ad7e4b811a0d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a149f6-8809-745a-8ff5-ad7e4b811a0d",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50165260",
  "filing_date": "2026-10-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Resilient Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}